Illumina Inc (ILMN.OQ)
18 Dec 2014
|Market Cap (Mil.):||$25,731.82|
|Shares Outstanding (Mil.):||142.00|
CHICAGO - Gene sequencing equipment maker Illumina has teamed up with the U.S. government and academic researchers at the Broad Institute in Boston to train scientists in West Africa to improve tracking of how the Ebola virus is mutating in hopes of fighting it more effectively.
CHICAGO, Nov 19 - Gene sequencing equipment maker Illumina has teamed up with the U.S. government and academic researchers at the Broad Institute in Boston to train scientists in West Africa to improve tracking of how the Ebola virus is mutating in hopes of fighting it more effectively.
* Signs exclusive agreement with Illumina to launch a next-generation sequencing (NGS) epidemiology solution for service labs
|Affymetrix, Inc. (AFFX.OQ)||$9.64||+0.22|
|Agilent Technologies Inc (A.N)||$40.70||+0.94|
|Helicos BioSciences Corp. (HLCSQ.PK)||$0.00||--|
|General Electric Company (GE.N)||$25.14||+0.71|
|Life Technologies Corp (LIFE.OQ)||--||--|
|Luminex Corporation (LMNX.OQ)||$18.37||+0.41|
|Roche Holding Ltd. (ROG.VX)||CHF288.70||--|
|Pacific Biosciences of California (PACB.OQ)||$7.27||+0.29|
|Qiagen NV (QGEN.OQ)||$23.71||+0.69|
|Complete Genomics, Inc. (GNOM.OQ)||--||--|
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Trading Report for (ILMN). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: New Constructs, LLC
"The Economy Matters" Report for ILMN: the economy's impact on ILMN's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.